Micro-environmental signals directing human epidermal Langerhans cell differentiation.

[1]  M. Haniffa,et al.  Antigen-Presenting Cells in the Skin. , 2017, Annual review of immunology.

[2]  Haisheng Yu,et al.  Human Blood CD1c+ Dendritic Cells Encompass CD5high and CD5low Subsets That Differ Significantly in Phenotype, Gene Expression, and Functions , 2017, The Journal of Immunology.

[3]  T. Geijtenbeek,et al.  Interplay between HIV-1 innate sensing and restriction in mucosal dendritic cells: balancing defense and viral transmission. , 2017, Current opinion in virology.

[4]  C. Fieber,et al.  Human skin dendritic cell fate is differentially regulated by the monocyte identity factor Kruppel-like factor 4 during steady state and inflammation , 2016, The Journal of allergy and clinical immunology.

[5]  C. Mueller,et al.  Of skin and bone: did Langerhans cells and osteoclasts evolve from a common ancestor? , 2019, Journal of anatomy.

[6]  J. Austyn.  Dendritic Cells in the Immune System-History, Lineages, Tissues, Tolerance, and Immunity. , 2016, Microbiology spectrum.

[7]  Xiaodi Wu,et al.  Mafb lineage tracing to distinguish macrophages from other immune lineages reveals dual identity of Langerhans cells , 2016, The Journal of experimental medicine.

[8]  N. McGovern,et al.  Unsupervised High-Dimensional Analysis Aligns Dendritic Cells across Tissues and Species , 2016, Immunity.

[9]  Q. Mi,et al.  TGF‐β1‐induced transcription factor networks in Langerhans cell development and maintenance , 2016, Allergy.

[10]  F. Duteille,et al.  Functional Langerinhigh-Expressing Langerhans-like Cells Can Arise from CD14highCD16− Human Blood Monocytes in Serum-Free Condition , 2016, The Journal of Immunology.

[11]  F. Ginhoux,et al.  Comparative genomics analysis of mononuclear phagocyte subsets confirms homology between lymphoid tissue-resident and dermal XCR1+ DCs in mouse and human and distinguishes them from Langerhans cells , 2016, Journal of immunological methods.

[12]  M. Collin,et al.  Langerhans cell origin and regulation , 2016, Current opinion in hematology.

[13]  Maxim N. Artyomov,et al.  Modular expression analysis reveals functional conservation between human Langerhans cells and mouse cross-priming dendritic cells , 2015, The Journal of experimental medicine.

[14]  P. Cauchy,et al.  The RUNX1–PU.1 axis in the control of hematopoiesis , 2015, International Journal of Hematology.

[15]  M. Haniffa,et al.  CD1c+ blood dendritic cells have Langerhans cell potential. , 2015, Blood.

[16]  V. Soumelis,et al.  Human blood BDCA-1 dendritic cells differentiate into Langerhans-like cells with thymic stromal lymphopoietin and TGF-β. , 2014, Blood.

[17]  Kaibo Duan,et al.  Human Dermal CD14+ Cells Are a Transient Population of Monocyte-Derived Macrophages , 2014, Immunity.

[18]  M. Mildner,et al.  Human embryonic epidermis contains a diverse Langerhans cell precursor pool , 2014, Development.

[19]  M. Sixt,et al.  Langerhans cell maturation is accompanied by induction of N‐cadherin and the transcriptional regulators of epithelial–mesenchymal transition ZEB1/2 , 2013, European journal of immunology.

[20]  Stéphane Chevrier,et al.  Langerhans cells are generated by two distinct PU.1-dependent transcriptional networks , 2013, The Journal of experimental medicine.

[21]  D. Graf,et al.  Identification of bone morphogenetic protein 7 (BMP7) as an instructive factor for human epidermal Langerhans cell differentiation , 2013, The Journal of experimental medicine.

[22]  H. Strobl,et al.  β-Catenin promotes the differentiation of epidermal Langerhans dendritic cells. , 2013, The Journal of investigative dermatology.

[23]  M. Zenke,et al.  TGFβ1 microenvironment determines dendritic cell development , 2013, Oncoimmunology.

[24]  T. Geijtenbeek,et al.  E-cadherin interactions are required for Langerhans cell differentiation , 2012, European journal of immunology.

[25]  M. Kauer,et al.  Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells. , 2012, Blood.

[26]  F. Tacke,et al.  Two distinct types of Langerhans cells populate the skin during steady state and inflammation. , 2012, Immunity.

[27]  Q. Mi,et al.  Lack of microRNA miR‐150 reduces the capacity of epidermal Langerhans cell cross‐presentation , 2012, Experimental dermatology.

[28]  G. Lemke,et al.  Identification of Axl as a downstream effector of TGF-β1 during Langerhans cell differentiation and epidermal homeostasis , 2012, The Journal of experimental medicine.

[29]  C. Birchmeier,et al.  The HGF Receptor/Met Tyrosine Kinase Is a Key Regulator of Dendritic Cell Migration in Skin Immunity , 2012, The Journal of Immunology.

[30]  J. Nickel,et al.  Promiscuity and specificity in BMP receptor activation , 2012, FEBS letters.

[31]  P. Coffer,et al.  Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy. , 2012, Blood.

[32]  A. Mantovani,et al.  Regulation and function of the E-cadherin/catenin complex in cells of the monocyte-macrophage lineage and DCs. , 2012, Blood.

[33]  Jean Kanitakis,et al.  Self‐renewal capacity of human epidermal Langerhans cells: observations made on a composite tissue allograft , 2011, Experimental dermatology.

[34]  B. Pulendran,et al.  Activation of β-Catenin in Dendritic Cells Regulates Immunity Versus Tolerance in the Intestine , 2010, Science.

[35]  H. Fehling,et al.  Dicer-Dependent MicroRNAs Control Maturation, Function, and Maintenance of Langerhans Cells In Vivo , 2010, The Journal of Immunology.

[36]  H. Strobl,et al.  miR-146a Is Differentially Expressed by Myeloid Dendritic Cell Subsets and Desensitizes Cells to TLR2-Dependent Activation , 2010, The Journal of Immunology.

[37]  P. Chambon,et al.  Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network , 2009, The Journal of experimental medicine.

[38]  H. Strobl,et al.  Aryl Hydrocarbon Receptor Activation Inhibits In Vitro Differentiation of Human Monocytes and Langerhans Dendritic Cells1 , 2009, The Journal of Immunology.

[39]  Chunming Liu,et al.  KLF4 gene expression is inhibited by the notch signaling pathway that controls goblet cell differentiation in mouse gastrointestinal tract. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[40]  C. Fiala,et al.  HLA-DR+ leukocytes acquire CD1 antigens in embryonic and fetal human skin and contain functional antigen-presenting cells , 2009, The Journal of experimental medicine.

[41]  A. Elia,et al.  Activin A Induces Langerhans Cell Differentiation In Vitro and in Human Skin Explants , 2008, PloS one.

[42]  R. Randall,et al.  Transforming Growth Factor (cid:2) -Induced Smad1/5 Phosphorylation in Epithelial Cells Is Mediated by Novel Receptor Complexes and Is Essential for Anchorage-Independent Growth (cid:1) † , 2022 .

[43]  M. McDevitt,et al.  Kruppel-Like Factor 4 Is Essential for Inflammatory Monocyte Differentiation In Vivo. , 2007 .

[44]  J. Connolly,et al.  Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. , 2007, Immunity.

[45]  K. Kaestner,et al.  The Kruppel‐like factor KLF4 is a critical regulator of monocyte differentiation , 2007, The EMBO journal.

[46]  J. Bos,et al.  Cutting Edge: Loss of TLR2, TLR4, and TLR5 on Langerhans Cells Abolishes Bacterial Recognition1 , 2007, The Journal of Immunology.

[47]  M. Darmon,et al.  Human epidermis reconstructed in vitro: A model to study keratinocyte differentiation and its modulation by retinoic acid , 1989, In Vitro Cellular & Developmental Biology.

[48]  H. Ploegh,et al.  Behavioral responses of epidermal Langerhans cells in situ to local pathological stimuli. , 2006, The Journal of investigative dermatology.

[49]  H. Strobl,et al.  Differential involvement of PU.1 and Id2 downstream of TGF-beta1 during Langerhans-cell commitment. , 2006, Blood.

[50]  F. Ginhoux,et al.  Langerhans cells arise from monocytes in vivo , 2006, Nature Immunology.

[51]  J. Nishioka,et al.  A novel role for Notch ligand Delta‐1 as a regulator of human Langerhans cell development from blood monocytes , 2005, Journal of leukocyte biology.

[52]  S. Werner,et al.  Langerhans cells are strongly reduced in the skin of transgenic mice overexpressing follistatin in the epidermis. , 2005, European journal of cell biology.

[53]  Xin-Hua Feng,et al.  Latent TGFβ1 overexpression in keratinocytes results in a severe psoriasis‐like skin disorder , 2004, The EMBO journal.

[54]  Steffen Jung,et al.  Runx3 regulates mouse TGF‐β‐mediated dendritic cell function and its absence results in airway inflammation , 2004, The EMBO journal.

[55]  S. Rose-John,et al.  Transcriptional profiling identifies Id2 function in dendritic cell development , 2003, Nature Immunology.

[56]  I. Weissman,et al.  Langerhans cells renew in the skin throughout life under steady-state conditions , 2002, Nature Immunology.

[57]  W. Birchmeier,et al.  The impact of c‐met/scatter factor receptor on dendritic cell migration , 2002, European journal of immunology.

[58]  D. Tenen,et al.  Reciprocal Roles for CCAAT/Enhancer Binding Protein (C/EBP) and PU.1 Transcription Factors in Langerhans Cell Commitment , 2002, The Journal of experimental medicine.

[59]  Simon C Watkins,et al.  Dermal-resident CD14+ cells differentiate into Langerhans cells , 2001, Nature Immunology.

[60]  I. Bernstein,et al.  The Notch ligand, Delta-1, inhibits the differentiation of monocytes into macrophages but permits their differentiation into dendritic cells. , 2001, Blood.

[61]  A. G. de Herreros,et al.  Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling , 2001, The Journal of cell biology.

[62]  O. Majdic,et al.  Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation. , 2000, Blood.

[63]  O. Majdic,et al.  Functional Involvement of E-Cadherin in TGF-β1-Induced Cell Cluster Formation of In Vitro Developing Human Langerhans-Type Dendritic Cells1 , 2000, The Journal of Immunology.

[64]  F. Watt,et al.  Stimulation of human epidermal differentiation by Delta–Notch signalling at the boundaries of stem-cell clusters , 2000, Current Biology.

[65]  E. Kriehuber,et al.  CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner. , 1999, Journal of immunology.

[66]  C. Caux,et al.  Respective involvement of TGF‐β and IL‐4 in the development of Langerhans cells and non‐Langerhans dendritic cells from CD34+ progenitors , 1999, Journal of leukocyte biology.

[67]  O. Majdic,et al.  Identification of CD68+lin- peripheral blood cells with dendritic precursor characteristics. , 1998, Journal of immunology.

[68]  F. Geissmann,et al.  Transforming Growth Factor (cid:98) 1, in the Presence of Granulocyte/Macrophage Colony-stimulating Factor and Interleukin 4, Induces Differentiation of Human Peripheral Blood Monocytes into Dendritic Langerhans Cells , 2022 .

[69]  O. Majdic,et al.  flt3 ligand in cooperation with transforming growth factor-beta1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions. , 1997, Blood.

[70]  O. Majdic,et al.  TGF-beta 1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis. , 1997, Journal of immunology.

[71]  M. Udey.  Cadherins and Langerhans cell immunobiology. , 1997, Clinical and experimental immunology.

[72]  J. Letterio,et al.  A Role for Endogenous Transforming Growth Factor β1 in Langerhans Cell Biology:  The Skin of   Transforming Growth Factor β1 Null Mice Is Devoid of  Epidermal Langerhans Cells , 1996, The Journal of experimental medicine.

[73]  P. Schirmacher,et al.  Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions , 1996, The Journal of cell biology.

[74]  O. Majdic,et al.  TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. , 1996, Journal of immunology.

[75]  A. Blauvelt,et al.  Human Langerhans cells express E-cadherin. , 1995, The Journal of investigative dermatology.

[76]  G. Krystal,et al.  Transforming growth factor beta 1 is an inducer of erythroid differentiation , 1994, The Journal of experimental medicine.

[77]  R. Derynck,et al.  Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor. , 1993, Science.

[78]  M. Amagai,et al.  Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin , 1993, Nature.

[79]  J. Banchereau,et al.  GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells , 1992, Nature.

[80]  R. Maki,et al.  Transforming growth factor-beta enhances the M-CSF and GM-CSF-stimulated proliferation of macrophages. , 1992, Journal of immunology.

[81]  J. Tikerpae,et al.  Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood. , 1990, Blood.